CA
PRAH

Crewe Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Crewe Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-40
Closed -$3K – 289
2018
Q1 		$3K Hold
40
– – ﹤0.01% 254
2017
Q4 		$4K Buy
+40
New +$3.33K ﹤0.01% 245

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crewe Advisors's PRAH Position: Q2 2018 in Review

Crewe Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2018, closing a stake of 40 shares — an estimated $3K sold.

Crewe Advisors first reported a position in PRAH in Q4 2017 and held it in 2 quarters. The position peaked at $4K in Q4 2017. 300 funds tracked by Wall St. Rank hold PRAH as of Q2 2018.

  • Crewe Advisors reported no remaining PRA Health Sciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • Crewe Advisors sold 40 PRA Health Sciences, Inc. shares in Q2 2018, an estimated $3K.
  • Crewe Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 2 quarters.
  • Crewe Advisors's PRA Health Sciences, Inc. position peaked at $4K in Q4 2017.
  • 300 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2018.

Based on Crewe Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.